Merih Kızıl Çakar

6PUBLICATIONS
5CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 12, 2022
Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease.

Burcu Aslan Candır, Tuğçe Nur Yiğenoğlu, Merih Kızıl Çakar

|Jan 10, 2022
Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities.

Burcu Aslan Candır, Tuğçe Nur Yiğenoğlu, Merih Kızıl Çakar

|Feb 27, 2020
The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience.

Hikmettullah Batgi, Alparslan Merdin, Mehmet Sinan Dal

|Feb 08, 2020
A multiple myeloma patient who developed ischemic colitis during lenalidomide treatment: A rare case report.

Hikmettullah Batgi, Mehmet Sinan Dal, Alparslan Merdin

|Dec 12, 2019
Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor.

Alparslan Merdin, Merih Kızıl Çakar, Mehmet Sinan Dal

|Apr 04, 2019
The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma.

Merih K Çakar, Emre Tekgündüz, Mehmet S Dal

Pageof 1